PharmID, Inc. — Form D
PharmID, Inc. of SEATTLE, WA, a company, filed a Form D exempt-offering notice with the SEC on 2017-10-11. The offering totals $1.1M, of which $1.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-10-11
- Form: D
- Accession: 0001719289-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $1.1M
- Amount sold: $1.0M
- Remaining: $35K
- Investors: 11
- Date of first sale: 2017-09-22
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-296438
Issuer
- Name: PharmID, Inc.
- CIK: 0001719289
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 2157 N. NORTHLAKE WAY #240, SEATTLE, WA, 98103
- Phone: 206-992-3589
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Brian Marquardt | Director | Seattle, WA |
| Brian Marquardt | Executive Officer | Seattle, WA |
| Christopher Swasand | Director | Seattle, WA |
| Tom Pierson | Executive Officer | Seattle, WA |
| J. Scott Van Vuren | Director | Seattle, WA |
| J. Scott Van Vuren | Executive Officer | Seattle, WA |
| Scott Van Vuren | Director | Seattle, WA |
| Tim Gibbons | Director | Seattle, WA |
| Tim Gibbons | Executive Officer | Seattle, WA |
Other filings by this issuer (2)
More